3.5 – 5.5

1.2 – 7.6

25 – 165

< or – 1:80

• Negative: <12 APL

• Indeterminate: 12-20 APL

• Low-medium positive: >20-80 APL

• Positive: >80 APL

• Negative: <15 GPL

• Indeterminate: 15-20 GPL

• Low-medium positive: >20-80 GPL

• Positive: >80 GPL

• Negative: <13 MPL

• Indeterminate: 13-20 MPL

• Low-medium positive: >20-80 MPL

• Positive: >80 MPL

Negative <20

Weak positive 20 – 39

Moderate positive 40 – 59

Strong positive >59

0 – 0.9

Negative <5

Equivocal 5 – 9

Positive >9

0 – 9

< or = 1:20

0 – 3.5

0 -0.9

0 – 20

0 – 20

0.0 – 1.2

0.0 – 0.4

8.7 – 10.2

20 – 32

97 – 108

90 – 180

9 – 36

< 0.8mg/dL (8.0mg/L

0.57 – 1.0

24- 173

< 59

0 – 30 (will vary with age)

13- 150

> 3.0

34.0 – 46.6

11.1 – 15.9

– Hemoglobin(Hb) A1c:4.8% to5.6%

– Increased risk for diabetes: 5.7% to 6.4%

– Diabetes: > 6.5%

– Glycemic control for adults with diabetes: < 7.0%

Negative

35 – 155

15 – 15%

15 – 65

22 – 34

140 – 415

3.5 – 5.2

6.0 – 8.5

0.8 – 1.2 Unless Anticoagulated

0 – 13.9

0 – 0.9

0 – 0.9

0 – 0.9

– Albumin: 3.2 – 5.6 g/dL

– alpha1-globulin: 0.1 – 0.4 g/dL

– alpha2-globulin: 0.4 – 1.2 g/dL

– beta-globulin: 0.6 – 1.3 g/dL

– gamma-globulin: 0.5 – 1.6 g/dL

– Total protein: 6.0 – 8.5 g/dL

– Globulin: 2.0 – 4.5 g/dL

– A:G ratio: 0.7 – 2.0

0 – 40

0- 40

0 – 0.9

134-144

348-1197

– Negative: 0-3 units/mL

– Weak positive: 4-10 units/mL

– Positive: >10 units/mL

– Negative: <6 units/mL

– Weak positive: 6-9 units/mL

– Positive: >9 units/mL

250 – 450

0.450 – 4.500

4.5 – 12.0 ?g/dL

3.7 – 8.6; therapeutic target for gout <6

211 – 946

30 – 100

4.0 – 10.5